Regenxbio (RGNX) Share-based Compensation (2014 - 2025)
Regenxbio (RGNX) reported Share-based Compensation of $8.38 million for Q4 2025, down 12.2% from $9.54 million a year earlier and down 6.9% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Share-based Compensation (2014 - 2025) Analysis & Trends
For FY2025, Regenxbio posted Share-based Compensation of $34.56 million, down 10.1% from FY2024.
- Share-based Compensation has declined for three consecutive years, though with a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $38.46 million in FY2024 (-4.5%), $40.27 million in FY2023 (-1.3%), $40.79 million in FY2022 (+5.1%) and $38.81 million in FY2021 (+21.5%).
- The Q4 2025 figure ranks as the lowest quarterly Share-based Compensation since Q4 2023.
- Year over year, Share-based Compensation has now declined in each of the last four quarters, with an average decline of 6.7% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q1 2021 (growth of 23.7%); the low point was Q1 2024 (a decline of 14.3%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $9 million (Q3 2025), $8.65 million (Q2 2025) and $8.54 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Regenxbio | 401.90 Mn | -531.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8.38 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 8.65 Mn |
| Mar 31, 2025 | 8.54 Mn |
| Dec 31, 2024 | 9.54 Mn |
| Sep 30, 2024 | 9.88 Mn |
| Jun 30, 2024 | 9.44 Mn |
| Mar 31, 2024 | 9.60 Mn |
| Dec 31, 2023 | 8.34 Mn |
| Sep 30, 2023 | 10.22 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 11.21 Mn |
| Dec 31, 2022 | 9.41 Mn |
| Sep 30, 2022 | 10.25 Mn |
| Jun 30, 2022 | 10.34 Mn |
| Mar 31, 2022 | 10.80 Mn |
| Dec 31, 2021 | 9.16 Mn |
| Sep 30, 2021 | 9.73 Mn |
| Jun 30, 2021 | 9.99 Mn |
| Mar 31, 2021 | 9.92 Mn |
API Access
Regenxbio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();